Skip to content
MARKETS / NASDAQ / BWAY
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP

Brainsway Ltd. BWAY

8 fiscal years on record · USD · FY2024 reported · SEC filings only
$41.0M
▲ 29.0% YoY
$2.9M
Growth
USD 41.0M
Revenue, FY2024 · full 8-year series below
Revenue $M Net income $M
FY2024 · Revenue 41.0 · Net income 2.9
20M40M-5M-10M20172018201920202021202220232024
Compound annual growth
+11.4%
+12.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +12.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
7 cents
of every revenue dollar became profit
Operating margin Net margin
FY2024 · Operating 3.4% · Net 7.1%
2%4%6%-20%-40%-60%20172018201920202021202220232024
ROE

Not available in our data for this period.

Cash & shareholders
returned in FY2024 · dividends + net buybacks
Free cash flow $M
FY2021 · FCF -1.4
-4M-8M20172018201920202021202220232024

Total assetsUSD 94.3M
CashUSD 69.3M
Current ratio5.19×

Not available: we don't have the total debt figure for this period.

The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20242023202220212020201920182017
Revenue $B0.00.00.00.00.00.00.00.0
Operating income $B0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B········
Income tax $B0.00.00.00.00.00.00.00.0
Net income $B0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B···−0.0−0.0−0.0−0.0−0.0
EPS, diluted $0.05−0.13−0.40−0.21····
Dividend / sh $········
Payout %········
ROE %········
Shares out B0.040.030.030.030.020.020.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 34 reconciliationsAUDITED

Reconciled in 8 of 19 fiscal years. 61 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inoutside the United States — SEC code L3
Fiscal year endsnot stated in the filings
Data on record since2017

Share this section

Download image